These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21427728)

  • 1. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.
    Osorio A; Milne RL; Alonso R; Pita G; Peterlongo P; Teulé A; Nathanson KL; Domchek SM; Rebbeck T; Lasa A; Konstantopoulou I; Hogervorst FB; Verhoef S; van Dooren MF; Jager A; Ausems MG; Aalfs CM; van Asperen CJ; Vreeswijk M; Waisfisz Q; Van Roozendaal CE; Ligtenberg MJ; ; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Curzon B; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Adlard J; Eccles D; Ong KR; Douglas F; Downing S; Brewer C; Walker L; Nevanlinna H; Aittomäki K; Couch FJ; Fredericksen Z; Lindor NM; Godwin A; Isaacs C; Caligo MA; Loman N; Jernström H; Barbany-Bustinza G; Liljegren A; Ehrencrona H; Stenmark-Askmalm M; ; Feliubadaló L; Manoukian S; Peissel B; Zaffaroni D; Bonanni B; Fortuzzi S; Johannsson OT; Chenevix-Trench G; Chen XC; Beesley J; Spurdle AB; ; Sinilnikova OM; Healey S; McGuffog L; Antoniou AC; Brunet J; Radice P; Benítez J;
    Br J Cancer; 2011 Apr; 104(8):1356-61. PubMed ID: 21427728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
    Osorio A; Milne RL; Kuchenbaecker K; Vaclová T; Pita G; Alonso R; Peterlongo P; Blanco I; de la Hoya M; Duran M; Díez O; Ramón Y Cajal T; Konstantopoulou I; Martínez-Bouzas C; Andrés Conejero R; Soucy P; McGuffog L; Barrowdale D; Lee A; ; Arver B; Rantala J; Loman N; Ehrencrona H; Olopade OI; Beattie MS; Domchek SM; Nathanson K; Rebbeck TR; Arun BK; Karlan BY; Walsh C; Lester J; John EM; Whittemore AS; Daly MB; Southey M; Hopper J; Terry MB; Buys SS; Janavicius R; Dorfling CM; van Rensburg EJ; Steele L; Neuhausen SL; Ding YC; Hansen TV; Jønson L; Ejlertsen B; Gerdes AM; Infante M; Herráez B; Moreno LT; Weitzel JN; Herzog J; Weeman K; Manoukian S; Peissel B; Zaffaroni D; Scuvera G; Bonanni B; Mariette F; Volorio S; Viel A; Varesco L; Papi L; Ottini L; Tibiletti MG; Radice P; Yannoukakos D; Garber J; Ellis S; Frost D; Platte R; Fineberg E; Evans G; Lalloo F; Izatt L; Eeles R; Adlard J; Davidson R; Cole T; Eccles D; Cook J; Hodgson S; Brewer C; Tischkowitz M; Douglas F; Porteous M; Side L; Walker L; Morrison P; Donaldson A; Kennedy J; Foo C; Godwin AK; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S; Damiola F; Poppe B; Claes K; Piedmonte M; Tucker K; Backes F; Rodríguez G; Brewster W; Wakeley K; Rutherford T; Caldés T; Nevanlinna H; Aittomäki K; Rookus MA; van Os TA; van der Kolk L; de Lange JL; Meijers-Heijboer HE; van der Hout AH; van Asperen CJ; Gómez Garcia EB; Hoogerbrugge N; Collée JM; van Deurzen CH; van der Luijt RB; Devilee P; ; Olah E; Lázaro C; Teulé A; Menéndez M; Jakubowska A; Cybulski C; Gronwald J; Lubinski J; Durda K; Jaworska-Bieniek K; Johannsson OT; Maugard C; Montagna M; Tognazzo S; Teixeira MR; Healey S; ; Olswold C; Guidugli L; Lindor N; Slager S; Szabo CI; Vijai J; Robson M; Kauff N; Zhang L; Rau-Murthy R; Fink-Retter A; Singer CF; Rappaport C; Geschwantler Kaulich D; Pfeiler G; Tea MK; Berger A; Phelan CM; Greene MH; Mai PL; Lejbkowicz F; Andrulis I; Mulligan AM; Glendon G; Toland AE; Bojesen A; Pedersen IS; Sunde L; Thomassen M; Kruse TA; Jensen UB; Friedman E; Laitman Y; Shimon SP; Simard J; Easton DF; Offit K; Couch FJ; Chenevix-Trench G; Antoniou AC; Benitez J
    PLoS Genet; 2014 Apr; 10(4):e1004256. PubMed ID: 24698998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Wang X; Pankratz VS; Fredericksen Z; Tarrell R; Karaus M; McGuffog L; Pharaoh PD; Ponder BA; Dunning AM; Peock S; Cook M; Oliver C; Frost D; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Houdayer C; ; Hogervorst FB; Hooning MJ; Ligtenberg MJ; ; Spurdle A; Chenevix-Trench G; ; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Domchek SM; Nathanson KL; Rebbeck TR; Singer CF; Gschwantler-Kaulich D; Dressler C; Fink A; Szabo CI; Zikan M; Foretova L; Claes K; Thomas G; Hoover RN; Hunter DJ; Chanock SJ; Easton DF; Antoniou AC; Couch FJ
    Hum Mol Genet; 2010 Jul; 19(14):2886-97. PubMed ID: 20418484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).
    Chenevix-Trench G; Milne RL; Antoniou AC; Couch FJ; Easton DF; Goldgar DE;
    Breast Cancer Res; 2007; 9(2):104. PubMed ID: 17466083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
    Couch FJ; Sinilnikova O; Vierkant RA; Pankratz VS; Fredericksen ZS; Stoppa-Lyonnet D; Coupier I; Hughes D; Hardouin A; Berthet P; Peock S; Cook M; Baynes C; Hodgson S; Morrison PJ; Porteous ME; Jakubowska A; Lubinski J; Gronwald J; Spurdle AB; ; Schmutzler R; Versmold B; Engel C; Meindl A; Sutter C; Horst J; Schaefer D; Offit K; Kirchhoff T; Andrulis IL; Ilyushik E; Glendon G; Devilee P; Vreeswijk MP; Vasen HF; Borg A; Backenhorn K; Struewing JP; Greene MH; Neuhausen SL; Rebbeck TR; Nathanson K; Domchek S; Wagner T; Garber JE; Szabo C; Zikan M; Foretova L; Olson JE; Sellers TA; Lindor N; Nevanlinna H; Tommiska J; Aittomaki K; Hamann U; Rashid MU; Torres D; Simard J; Durocher F; Guenard F; Lynch HT; Isaacs C; Weitzel J; Olopade OI; Narod S; Daly MB; Godwin AK; Tomlinson G; Easton DF; Chenevix-Trench G; Antoniou AC;
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1416-21. PubMed ID: 17627006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
    Osorio A; Milne RL; Pita G; Peterlongo P; Heikkinen T; Simard J; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; Healey S; ; Neuhausen SL; Ding YC; Couch FJ; Wang X; Lindor N; Manoukian S; Barile M; Viel A; Tizzoni L; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai P; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; Weerasooriya N; ; Gerdes AM; Thomassen M; Cruger DG; Caligo MA; Friedman E; Kaufman B; Laitman Y; Cohen S; Kontorovich T; Gershoni-Baruch R; Dagan E; Jernström H; Askmalm MS; Arver B; Malmer B; ; Domchek SM; Nathanson KL; Brunet J; Ramón Y Cajal T; Yannoukakos D; Hamann U; ; Hogervorst FB; Verhoef S; Gómez García EB; Wijnen JT; van den Ouweland A; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Cook J; Hodgson S; Morrison PJ; Douglas F; Godwin AK; ; Sinilnikova OM; Barjhoux L; Stoppa-Lyonnet D; Moncoutier V; Giraud S; Cassini C; Olivier-Faivre L; Révillion F; Peyrat JP; Muller D; Fricker JP; Lynch HT; John EM; Buys S; Daly M; Hopper JL; Terry MB; Miron A; Yassin Y; Goldgar D; ; Singer CF; Gschwantler-Kaulich D; Pfeiler G; Spiess AC; Hansen TV; Johannsson OT; Kirchhoff T; Offit K; Kosarin K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Varon-Mateeva R; Schaefer D; Froster UG; Caldes T; de la Hoya M; McGuffog L; Antoniou AC; Nevanlinna H; Radice P; Benítez J;
    Br J Cancer; 2009 Dec; 101(12):2048-54. PubMed ID: 19920816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
    Hamdi Y; Soucy P; Kuchenbaeker KB; Pastinen T; Droit A; Lemaçon A; Adlard J; Aittomäki K; Andrulis IL; Arason A; Arnold N; Arun BK; Azzollini J; Bane A; Barjhoux L; Barrowdale D; Benitez J; Berthet P; Blok MJ; Bobolis K; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caligo MA; Chiquette J; Chung WK; Claes KB; Daly MB; Damiola F; Davidson R; De la Hoya M; De Leeneer K; Diez O; Ding YC; Dolcetti R; Domchek SM; Dorfling CM; Eccles D; Eeles R; Einbeigi Z; Ejlertsen B; ; Engel C; Gareth Evans D; Feliubadalo L; Foretova L; Fostira F; Foulkes WD; Fountzilas G; Friedman E; Frost D; Ganschow P; Ganz PA; Garber J; Gayther SA; ; Gerdes AM; Glendon G; Godwin AK; Goldgar DE; Greene MH; Gronwald J; Hahnen E; Hamann U; Hansen TV; Hart S; Hays JL; ; Hogervorst FB; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Joseph V; Just W; Kaczmarek K; Karlan BY; ; Kets CM; Kirk J; Kriege M; Laitman Y; Laurent M; Lazaro C; Leslie G; Lester J; Lesueur F; Liljegren A; Loman N; Loud JT; Manoukian S; Mariani M; Mazoyer S; McGuffog L; Meijers-Heijboer HE; Meindl A; Miller A; Montagna M; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Nussbaum RL; Olah E; Olopade OI; Ong KR; Oosterwijk JC; Osorio A; Papi L; Park SK; Pedersen IS; Peissel B; Segura PP; Peterlongo P; Phelan CM; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Richardson A; Robson M; Rodriguez GC; Rookus MA; Schmutzler RK; Sevenet N; Shah PD; Singer CF; Slavin TP; Snape K; Sokolowska J; Sønderstrup IM; Southey M; Spurdle AB; Stadler Z; Stoppa-Lyonnet D; Sukiennicki G; Sutter C; Tan Y; Tea MK; Teixeira MR; Teulé A; Teo SH; Terry MB; Thomassen M; Tihomirova L; Tischkowitz M; Tognazzo S; Toland AE; Tung N; van den Ouweland AM; van der Luijt RB; van Engelen K; van Rensburg EJ; Varon-Mateeva R; Wappenschmidt B; Wijnen JT; Rebbeck T; Chenevix-Trench G; Offit K; Couch FJ; Nord S; Easton DF; Antoniou AC; Simard J
    Breast Cancer Res Treat; 2017 Jan; 161(1):117-134. PubMed ID: 27796716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
    Mulligan AM; Couch FJ; Barrowdale D; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Robson M; Sherman M; Spurdle AB; Wappenschmidt B; Lee A; McGuffog L; Healey S; Sinilnikova OM; Janavicius R; Hansen Tv; Nielsen FC; Ejlertsen B; Osorio A; Muñoz-Repeto I; Durán M; Godino J; Pertesi M; Benítez J; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Bonanni B; Viel A; Pasini B; Papi L; Ottini L; Savarese A; Bernard L; Radice P; Hamann U; Verheus M; Meijers-Heijboer HE; Wijnen J; Gómez García EB; Nelen MR; Kets CM; Seynaeve C; Tilanus-Linthorst MM; van der Luijt RB; van Os T; Rookus M; Frost D; Jones JL; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Cook J; Donaldson A; Dorkins H; Gregory H; Eason J; Houghton C; Barwell J; Side LE; McCann E; Murray A; Peock S; Godwin AK; Schmutzler RK; Rhiem K; Engel C; Meindl A; Ruehl I; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Kast K; Preisler-Adams S; Varon-Mateeva R; Schoenbuchner I; Fiebig B; Heinritz W; Schäfer D; Gevensleben H; Caux-Moncoutier V; Fassy-Colcombet M; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Hardouin A; Berthet P; Muller D; Fricker JP; Mortemousque I; Pujol P; Coupier I; Lebrun M; Kientz C; Longy M; Sevenet N; Stoppa-Lyonnet D; Isaacs C; Caldes T; de la Hoya M; Heikkinen T; Aittomäki K; Blanco I; Lazaro C; Barkardottir RB; Soucy P; Dumont M; Simard J; Montagna M; Tognazzo S; D'Andrea E; Fox S; Yan M; Rebbeck T; Olopade O; Weitzel JN; Lynch HT; Ganz PA; Tomlinson GE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R; Gaudet M; Bhatia J; Kauff N; Singer CF; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Mai PL; Greene MH; Imyanitov E; O'Malley FP; Ozcelik H; Glendon G; Toland AE; Gerdes AM; Thomassen M; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Soller M; Henriksson K; Wachenfeldt vA; Arver B; Stenmark-Askmalm M; Karlsson P; Ding YC; Neuhausen SL; Beattie M; Pharoah PD; Moysich KB; Nathanson KL; Karlan BY; Gross J; John EM; Daly MB; Buys SM; Southey MC; Hopper JL; Terry MB; Chung W; Miron AF; Goldgar D; Chenevix-Trench G; Easton DF; Andrulis IL; Antoniou AC; ; ; ; ; ; ; ;
    Breast Cancer Res; 2011; 13(6):R110. PubMed ID: 22053997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Sinilnikova OM; Antoniou AC; Simard J; Healey S; Léoné M; Sinnett D; Spurdle AB; Beesley J; Chen X; ; Greene MH; Loud JT; Lejbkowicz F; Rennert G; Dishon S; Andrulis IL; ; Domchek SM; Nathanson KL; Manoukian S; Radice P; Konstantopoulou I; Blanco I; Laborde AL; Durán M; Osorio A; Benitez J; Hamann U; Hogervorst FB; van Os TA; Gille HJ; ; Peock S; Cook M; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Brewer C; ; Hughes DJ; Coupier I; Giraud S; Coulet F; Colas C; Soubrier F; Rouleau E; Bièche I; Lidereau R; Demange L; Nogues C; Lynch HT; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Sutter C; Deissler H; Schaefer D; Froster UG; ; Aittomäki K; Nevanlinna H; McGuffog L; Easton DF; Chenevix-Trench G; Stoppa-Lyonnet D;
    Br J Cancer; 2009 Oct; 101(8):1456-60. PubMed ID: 19707196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Kartsonaki C; Sinilnikova OM; Soucy P; McGuffog L; Healey S; Lee A; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Barile M; Pensotti V; Pasini B; Dolcetti R; Giannini G; Putignano AL; Varesco L; Radice P; Mai PL; Greene MH; Andrulis IL; Glendon G; Ozcelik H; Thomassen M; Gerdes AM; Kruse TA; Birk Jensen U; Crüger DG; Caligo MA; Laitman Y; Milgrom R; Kaufman B; Paluch-Shimon S; Friedman E; Loman N; Harbst K; Lindblom A; Arver B; Ehrencrona H; Melin B; ; Nathanson KL; Domchek SM; Rebbeck T; Jakubowska A; Lubinski J; Gronwald J; Huzarski T; Byrski T; Cybulski C; Gorski B; Osorio A; Ramón y Cajal T; Fostira F; Andrés R; Benitez J; Hamann U; Hogervorst FB; Rookus MA; Hooning MJ; Nelen MR; van der Luijt RB; van Os TA; van Asperen CJ; Devilee P; Meijers-Heijboer HE; Gómez Garcia EB; ; Peock S; Cook M; Frost D; Platte R; Leyland J; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Eccles D; Ong KR; Cook J; Douglas F; Paterson J; Kennedy MJ; Miedzybrodzka Z; ; Godwin A; Stoppa-Lyonnet D; Buecher B; Belotti M; Tirapo C; Mazoyer S; Barjhoux L; Lasset C; Leroux D; Faivre L; Bronner M; Prieur F; Nogues C; Rouleau E; Pujol P; Coupier I; Frénay M; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Tea MK; Pfeiler G; Dressler AC; Hansen Tv; Jønson L; Ejlertsen B; Barkardottir RB; Kirchhoff T; Offit K; Piedmonte M; Rodriguez G; Small L; Boggess J; Blank S; Basil J; Azodi M; Toland AE; Montagna M; Tognazzo S; Agata S; Imyanitov E; Janavicius R; Lazaro C; Blanco I; Pharoah PD; Sucheston L; Karlan BY; Walsh CS; Olah E; Bozsik A; Teo SH; Seldon JL; Beattie MS; van Rensburg EJ; Sluiter MD; Diez O; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ruehl I; Varon-Mateeva R; Kast K; Deissler H; Niederacher D; Arnold N; Gadzicki D; Schönbuchner I; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Dumont M; Chiquette J; Tischkowitz M; Chen X; Beesley J; Spurdle AB; ; Neuhausen SL; Chun Ding Y; Fredericksen Z; Wang X; Pankratz VS; Couch F; Simard J; Easton DF; Chenevix-Trench G;
    Hum Mol Genet; 2011 Aug; 20(16):3304-21. PubMed ID: 21593217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.
    Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Lubinski J
    Breast Cancer Res Treat; 2010 Jun; 121(3):639-49. PubMed ID: 19876733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
    Ramus SJ; Kartsonaki C; Gayther SA; Pharoah PD; Sinilnikova OM; Beesley J; Chen X; McGuffog L; Healey S; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Allavena A; Ottini L; Papi L; Gismondi V; Capra F; Radice P; Greene MH; Mai PL; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Gerdes AM; Kruse TA; Cruger D; Jensen UB; Caligo MA; Olsson H; Kristoffersson U; Lindblom A; Arver B; Karlsson P; Stenmark Askmalm M; Borg A; Neuhausen SL; Ding YC; Nathanson KL; Domchek SM; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Gronwald J; Górski B; Cybulski C; Dębniak T; Osorio A; Durán M; Tejada MI; Benítez J; Hamann U; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Bodmer D; Ausems MG; van Os TA; Asperen CJ; Blok MJ; Meijers-Heijboer HE; ; ; Peock S; Cook M; Oliver C; Frost D; Dunning AM; Evans DG; Eeles R; Pichert G; Cole T; Hodgson S; Brewer C; Morrison PJ; Porteous M; Kennedy MJ; Rogers MT; Side LE; Donaldson A; Gregory H; Godwin A; Stoppa-Lyonnet D; Moncoutier V; Castera L; Mazoyer S; Barjhoux L; Bonadona V; Leroux D; Faivre L; Lidereau R; Nogues C; Bignon YJ; Prieur F; Collonge-Rame MA; Venat-Bouvet L; Fert-Ferrer S; ; Miron A; Buys SS; Hopper JL; Daly MB; John EM; Terry MB; Goldgar D; ; Hansen Tv; Jønson L; Ejlertsen B; Agnarsson BA; Offit K; Kirchhoff T; Vijai J; Dutra-Clarke AV; Przybylo JA; Montagna M; Casella C; Imyanitov EN; Janavicius R; Blanco I; Lázaro C; Moysich KB; Karlan BY; Gross J; Beattie MS; Schmutzler R; Wappenschmidt B; Meindl A; Ruehl I; Fiebig B; Sutter C; Arnold N; Deissler H; Varon-Mateeva R; Kast K; Niederacher D; Gadzicki D; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Simard J; Soucy P; ; Spurdle AB; Holland H; Chenevix-Trench G; Easton DF; Antoniou AC;
    J Natl Cancer Inst; 2011 Jan; 103(2):105-16. PubMed ID: 21169536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
    Peterlongo P; Chang-Claude J; Moysich KB; Rudolph A; Schmutzler RK; Simard J; Soucy P; Eeles RA; Easton DF; Hamann U; Wilkening S; Chen B; Rookus MA; Schmidt MK; van der Baan FH; Spurdle AB; Walker LC; Lose F; Maia AT; Montagna M; Matricardi L; Lubinski J; Jakubowska A; Gómez Garcia EB; Olopade OI; Nussbaum RL; Nathanson KL; Domchek SM; Rebbeck TR; Arun BK; Karlan BY; Orsulic S; Lester J; Chung WK; Miron A; Southey MC; Goldgar DE; Buys SS; Janavicius R; Dorfling CM; van Rensburg EJ; Ding YC; Neuhausen SL; Hansen TV; Gerdes AM; Ejlertsen B; Jønson L; Osorio A; Martínez-Bouzas C; Benitez J; Conway EE; Blazer KR; Weitzel JN; Manoukian S; Peissel B; Zaffaroni D; Scuvera G; Barile M; Ficarazzi F; Mariette F; Fortuzzi S; Viel A; Giannini G; Papi L; Martayan A; Tibiletti MG; Radice P; Vratimos A; Fostira F; Garber JE; Donaldson A; Brewer C; Foo C; Evans DG; Frost D; Eccles D; Brady A; Cook J; Tischkowitz M; Adlard J; Barwell J; Walker L; Izatt L; Side LE; Kennedy MJ; Rogers MT; Porteous ME; Morrison PJ; Platte R; Davidson R; Hodgson SV; Ellis S; Cole T; ; Godwin AK; Claes K; Van Maerken T; Meindl A; Gehrig A; Sutter C; Engel C; Niederacher D; Steinemann D; Plendl H; Kast K; Rhiem K; Ditsch N; Arnold N; Varon-Mateeva R; Wappenschmidt B; Wang-Gohrke S; Bressac-de Paillerets B; Buecher B; Delnatte C; Houdayer C; Stoppa-Lyonnet D; Damiola F; Coupier I; Barjhoux L; Venat-Bouvet L; Golmard L; Boutry-Kryza N; Sinilnikova OM; Caron O; Pujol P; Mazoyer S; Belotti M; ; Piedmonte M; Friedlander ML; Rodriguez GC; Copeland LJ; de la Hoya M; Segura PP; Nevanlinna H; Aittomäki K; van Os TA; Meijers-Heijboer HE; van der Hout AH; Vreeswijk MP; Hoogerbrugge N; Ausems MG; van Doorn HC; Collée JM; ; Olah E; Diez O; Blanco I; Lazaro C; Brunet J; Feliubadalo L; Cybulski C; Gronwald J; Durda K; Jaworska-Bieniek K; Sukiennicki G; Arason A; Chiquette J; Teixeira MR; Olswold C; Couch FJ; Lindor NM; Wang X; Szabo CI; Offit K; Corines M; Jacobs L; Robson ME; Zhang L; Joseph V; Berger A; Singer CF; Rappaport C; Kaulich DG; Pfeiler G; Tea MK; Phelan CM; Greene MH; Mai PL; Rennert G; Mulligan AM; Glendon G; Tchatchou S; Andrulis IL; Toland AE; Bojesen A; Pedersen IS; Thomassen M; Jensen UB; Laitman Y; Rantala J; von Wachenfeldt A; Ehrencrona H; Askmalm MS; Borg Å; Kuchenbaecker KB; McGuffog L; Barrowdale D; Healey S; Lee A; Pharoah PD; Chenevix-Trench G; ; Antoniou AC; Friedman E
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):308-16. PubMed ID: 25336561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.
    Walker LC; Fredericksen ZS; Wang X; Tarrell R; Pankratz VS; Lindor NM; Beesley J; Healey S; Chen X; ; Stoppa-Lyonnet D; Tirapo C; Giraud S; Mazoyer S; Muller D; Fricker JP; Delnatte C; ; Schmutzler RK; Wappenschmidt B; Engel C; Schönbuchner I; Deissler H; Meindl A; Hogervorst FB; Verheus M; Hooning MJ; van den Ouweland AM; Nelen MR; Ausems MG; Aalfs CM; van Asperen CJ; Devilee P; Gerrits MM; Waisfisz Q; ; Szabo CI; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Harrington P; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Eccles D; Ong KR; Cook J; ; Rebbeck T; Nathanson KL; Domchek SM; Singer CF; Gschwantler-Kaulich D; Dressler AC; Pfeiler G; Godwin AK; Heikkinen T; Nevanlinna H; Agnarsson BA; Caligo MA; Olsson H; Kristoffersson U; Liljegren A; Arver B; Karlsson P; Melin B; ; Sinilnikova OM; McGuffog L; Antoniou AC; Chenevix-Trench G; Spurdle AB; Couch FJ
    Breast Cancer Res; 2010; 12(6):R102. PubMed ID: 21114847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
    Couch FJ; Gaudet MM; Antoniou AC; Ramus SJ; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; Wang X; Kirchhoff T; McGuffog L; Barrowdale D; Lee A; Healey S; Sinilnikova OM; Andrulis IL; ; Ozcelik H; Mulligan AM; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Caligo MA; von Wachenfeldt A; Barbany-Bustinza G; Loman N; Soller M; Ehrencrona H; Karlsson P; ; Nathanson KL; Rebbeck TR; Domchek SM; Jakubowska A; Lubinski J; Jaworska K; Durda K; Zlowocka E; Huzarski T; Byrski T; Gronwald J; Cybulski C; Górski B; Osorio A; Durán M; Tejada MI; Benitez J; Hamann U; Hogervorst FB; ; van Os TA; van Leeuwen FE; Meijers-Heijboer HE; Wijnen J; Blok MJ; Kets M; Hooning MJ; Oldenburg RA; Ausems MG; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Jacobs C; Eeles RA; Adlard J; Davidson R; Eccles DM; Cole T; Cook J; Paterson J; Brewer C; Douglas F; Hodgson SV; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Side LE; ; Bove B; Godwin AK; Stoppa-Lyonnet D; ; Fassy-Colcombet M; Castera L; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Bressac-de Paillerets B; Caron O; Pujol P; Coupier I; Delnatte C; Akloul L; Lynch HT; Snyder CL; Buys SS; Daly MB; Terry M; Chung WK; John EM; Miron A; Southey MC; Hopper JL; Goldgar DE; Singer CF; Rappaport C; Tea MK; Fink-Retter A; Hansen TV; Nielsen FC; Arason A; Vijai J; Shah S; Sarrel K; Robson ME; Piedmonte M; Phillips K; Basil J; Rubinstein WS; Boggess J; Wakeley K; Ewart-Toland A; Montagna M; Agata S; Imyanitov EN; Isaacs C; Janavicius R; Lazaro C; Blanco I; Feliubadalo L; Brunet J; Gayther SA; Pharoah PP; Odunsi KO; Karlan BY; Walsh CS; Olah E; Teo SH; Ganz PA; Beattie MS; van Rensburg EJ; Dorfling CM; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Heinritz W; Caldes T; de la Hoya M; Muranen TA; Nevanlinna H; Tischkowitz MD; Spurdle AB; Neuhausen SL; Ding YC; Lindor NM; Fredericksen Z; Pankratz VS; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Bernard L; Viel A; Giannini G; Varesco L; Radice P; Greene MH; Mai PL; Easton DF; Chenevix-Trench G; ; Offit K; Simard J;
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):645-57. PubMed ID: 22351618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.
    Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Scott RJ; McGuffog L; Healy S; Sinilnikova OM; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Paligo M; Aretini P; ; Kantala J; Aroer B; von Wachenfeldt A; Liljegren A; Loman N; Herbst K; Kristoffersson U; Rosenquist R; Karlsson P; Stenmark-Askmalm M; Melin B; Nathanson KL; Domchek SM; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Serrano P; Osorio A; Cajal TR; Tsitlaidou M; Benítez J; Gilbert M; ; Rookus M; Aalfs CM; Kluijt I; Boessenkool-Pape JL; Meijers-Heijboer HE; Oosterwijk JC; van Asperen CJ; Blok MJ; Nelen MR; van den Ouweland AM; Seynaeve C; van der Luijt RB; Devilee P; ; Easton DF; Peock S; Frost D; Platte R; Ellis SD; Fineberg E; Evans DG; Lalloo F; Eeles R; Jacobs C; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Godwin A; Bove B; ; Stoppa-Lyonnet D; Caux-Moncoutier V; Belotti M; Tirapo C; Mazoyer S; Barjhoux L; Boutry-Kryza N; Pujol P; Coupier I; Peyrat JP; Vennin P; Muller D; Fricker JP; Venat-Bouvet L; Johannsson OT; Isaacs C; Schmutzler R; Wappenschmidt B; Meindl A; Arnold N; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Preisler-Adams S; Simard J; Soucy P; Durocher F; Chenevix-Trench G; Beesley J; Chen X; ; Rebbeck T; Couch F; Wang X; Lindor N; Fredericksen Z; Pankratz VS; Peterlongo P; Bonanni B; Fortuzzi S; Peissel B; Szabo C; Mai PL; Loud JT; Lubinski J;
    Br J Cancer; 2012 Jun; 106(12):2016-24. PubMed ID: 22669161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.
    Stevens KN; Wang X; Fredericksen Z; Pankratz VS; Greene MH; Andrulis IL; Thomassen M; Caligo M; ; Nathanson KL; Jakubowska A; Osorio A; Hamann U; Godwin AK; Stoppa-Lyonnet D; Southey M; Buys SS; Singer CF; Hansen TV; Arason A; Offit K; Piedmonte M; Montagna M; Imyanitov E; Tihomirova L; Sucheston L; Beattie M; ; ; Neuhausen SL; ; Szabo CI; ; Simard J; Spurdle AB; Healey S; Chen X; Rebbeck TR; Easton DF; Chenevix-Trench G; Antoniou AC; Couch FJ
    Breast Cancer Res Treat; 2012 Nov; 136(1):295-302. PubMed ID: 23011509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.
    Antoniou AC; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; McGuffog L; Lee A; Barrowdale D; Healey S; Sinilnikova OM; Caligo MA; Loman N; Harbst K; Lindblom A; Arver B; Rosenquist R; Karlsson P; Nathanson K; Domchek S; Rebbeck T; Jakubowska A; Lubinski J; Jaworska K; Durda K; Złowowcka-Perłowska E; Osorio A; Durán M; Andrés R; Benítez J; Hamann U; Hogervorst FB; van Os TA; Verhoef S; Meijers-Heijboer HE; Wijnen J; Gómez Garcia EB; Ligtenberg MJ; Kriege M; Collée JM; Ausems MG; Oosterwijk JC; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Lalloo F; Jacobs C; Eeles R; Adlard J; Davidson R; Cole T; Cook J; Paterson J; Douglas F; Brewer C; Hodgson S; Morrison PJ; Walker L; Rogers MT; Donaldson A; Dorkins H; Godwin AK; Bove B; Stoppa-Lyonnet D; Houdayer C; Buecher B; de Pauw A; Mazoyer S; Calender A; Léoné M; Bressac-de Paillerets B; Caron O; Sobol H; Frenay M; Prieur F; Ferrer SU; Mortemousque I; Buys S; Daly M; Miron A; Terry MU; Hopper JL; John EM; Southey M; Goldgar D; Singer CF; Fink-Retter A; Tea MK; Kaulich DU; Hansen TV; Nielsen FC; Barkardottir RB; Gaudet M; Kirchhoff T; Joseph V; Dutra-Clarke A; Offit K; Piedmonte M; Kirk J; Cohn D; Hurteau J; Byron J; Fiorica J; Toland AE; Montagna M; Oliani C; Imyanitov E; Isaacs C; Tihomirova L; Blanco I; Lazaro C; Teulé A; Valle JD; Gayther SA; Odunsi K; Gross J; Karlan BY; Olah E; Teo SH; Ganz PA; Beattie MS; Dorfling CM; van Rensburg EU; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Schäfer D; Caldes T; de la Hoya M; Nevanlinna H; Muranen TA; Lespérance B; Spurdle AB; Neuhausen SL; Ding YC; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Bonanni B; Bernard L; Dolcetti R; Papi L; Ottini L; Radice P; Greene MH; Loud JT; Andrulis IL; Ozcelik H; Mulligan AU; Glendon G; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Chenevix-Trench G; Couch FJ; Simard J; Easton DF; ; ; ; ;
    Breast Cancer Res; 2012 Feb; 14(1):R33. PubMed ID: 22348646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.
    Kadouri L; Kote-Jarai Z; Hubert A; Durocher F; Abeliovich D; Glaser B; Hamburger T; Eeles RA; Peretz T
    Br J Cancer; 2004 May; 90(10):2002-5. PubMed ID: 15138485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.